| pubmed-article:9394097 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0030567 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0041177 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0242114 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0243144 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0105885 | lld:lifeskim |
| pubmed-article:9394097 | lifeskim:mentions | umls-concept:C0599682 | lld:lifeskim |
| pubmed-article:9394097 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:9394097 | pubmed:dateCreated | 1997-12-29 | lld:pubmed |
| pubmed-article:9394097 | pubmed:abstractText | For a few years, data on SPECT-imaging of dopamine transporters with the cocaine derivate [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I] beta-CIT) have been reported mostly in healthy subjects or animals. This study reflects our preliminary results with SPECT-imaging of dopamine transporters using the cocaine analogue 123-beta-CIT in patients with untreated (de novo) parkinsonism. | lld:pubmed |
| pubmed-article:9394097 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9394097 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9394097 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9394097 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9394097 | pubmed:issn | 1081-5589 | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:KuhnWW | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:ReinertBB | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:CoenenH HHH | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:EisingE GEG | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:ZanderCC | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:FarahatiJJ | lld:pubmed |
| pubmed-article:9394097 | pubmed:author | pubmed-author:MüllerT TTT | lld:pubmed |
| pubmed-article:9394097 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9394097 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:9394097 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9394097 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9394097 | pubmed:pagination | 448-52 | lld:pubmed |
| pubmed-article:9394097 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:meshHeading | pubmed-meshheading:9394097-... | lld:pubmed |
| pubmed-article:9394097 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9394097 | pubmed:articleTitle | SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease. | lld:pubmed |
| pubmed-article:9394097 | pubmed:affiliation | Clinic and Policlinic for Nuclear Medicine, University of Essen, Germany. | lld:pubmed |
| pubmed-article:9394097 | pubmed:publicationType | Journal Article | lld:pubmed |
